Analyst Consensus ?
ConsensusBuy32 ratings
Bullish2268.8%
Neutral1031.2%
Bearish00.0%
FN2 Earnings Intelligence
WESCO International, Inc. (WCC) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 30, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| RBC Capital | Outperform | Outperform | Maintain | Oct 14, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 12, 2026 |
| Stephens & Co. | Overweight | Equal Weight | Upgrade | Jul 14, 2026 |
| Keybanc | Overweight | Overweight | Maintain | May 1, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jan 16, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Sep 5, 2025 |
| Loop Capital | Buy | Buy | Maintain | Aug 5, 2025 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Aug 1, 2025 |
| Jefferies | Buy | Buy | Maintain | Dec 6, 2024 |
| Baird | Outperform | Outperform | Maintain | Nov 1, 2024 |
| Wells Fargo | Overweight | Overweight | Maintain | Apr 5, 2021 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Dec 8, 2020 |
| Buckingham Research | Neutral | Neutral | Maintain | Feb 3, 2020 |
| Buckingham | Neutral | Neutral | Maintain | Feb 3, 2020 |
| Longbow Research | Buy | Neutral | Upgrade | Jan 6, 2020 |
| Northcoast Research | Neutral | Buy | Downgrade | Aug 2, 2019 |
| Standpoint Research | Buy | Hold | Upgrade | Oct 12, 2018 |
| UBS | Neutral | Neutral | Maintain | Aug 30, 2018 |
| Credit Suisse | Outperform | Outperform | Maintain | Oct 31, 2017 |
| Morgan Stanley | Overweight | Overweight | Maintain | Oct 2, 2017 |
| William Blair | Outperform | Market Perform | Upgrade | Dec 5, 2016 |
| Macquarie | Neutral | Neutral | Maintain | Aug 25, 2016 |
| Susquehanna | Neutral | Neutral | Maintain | Apr 14, 2016 |
| Sterne Agee CRT | Neutral | Neutral | Maintain | Mar 22, 2016 |
| Cleveland Research | Neutral | Buy | Downgrade | Apr 20, 2015 |
| BB&T Capital | Hold | Buy | Downgrade | Mar 9, 2015 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jan 30, 2015 |
| Stifel | Buy | Buy | Maintain | Jan 30, 2015 |
| Citigroup | Buy | Buy | Maintain | Jul 25, 2014 |
| MKM Partners | Neutral | Neutral | Maintain | Apr 25, 2014 |
| Wunderlich Securities | Buy | Buy | Maintain | Jan 28, 2014 |
| Wunderlich | Buy | Buy | Maintain | Jan 28, 2014 |
Upside is calculated against the persisted current price $366.71. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Barclays | Analyst unavailable | $390 | $343.49 | +6.4% | Aug 3, 2026 |
| RBC Capital | Analyst unavailable | $430 | $343.19 | +17.3% | Jul 31, 2026 |
| RBC Capital | Deane Dray | $421 | $334.88 | +14.8% | Jul 16, 2026 |
| Stephens | Tommy Moll | $400 | $330.84 | +9.1% | Jul 14, 2026 |
| Wolfe Research | Analyst unavailable | $375 | $327.18 | +2.3% | Jul 9, 2026 |
| D.A. Davidson | Analyst unavailable | $440 | $347.79 | +20.0% | Jun 15, 2026 |
| Stephens | Analyst unavailable | $350 | $354.59 | -4.6% | May 4, 2026 |
| Barclays | Analyst unavailable | $375 | $354.59 | +2.3% | May 4, 2026 |
| Robert W. Baird | David Manthey | $375 | $342.13 | +2.3% | May 1, 2026 |
| Oppenheimer | Christopher Glynn | $395 | $344.04 | +7.7% | May 1, 2026 |
| KeyBanc | Analyst unavailable | $415 | $349.12 | +13.2% | May 1, 2026 |
| Raymond James | Analyst unavailable | $400 | $349.12 | +9.1% | May 1, 2026 |
| Barclays | Analyst unavailable | $313 | $311.18 | -14.6% | Feb 12, 2026 |
| KeyBanc | Ken Newman | $340 | $302.93 | -7.3% | Feb 11, 2026 |
| Oppenheimer | Analyst unavailable | $330 | $298.56 | -10.0% | Feb 11, 2026 |
| Robert W. Baird | Analyst unavailable | $307 | $285.8 | -16.3% | Feb 11, 2026 |
| KeyBanc | Analyst unavailable | $304 | $286.41 | -17.1% | Jan 26, 2026 |
| RBC Capital | Deane Dray | $316 | $283.03 | -13.8% | Jan 15, 2026 |
| Barclays | Analyst unavailable | $302 | $269.3 | -17.6% | Jan 12, 2026 |
| Wolfe Research | Analyst unavailable | $307 | $269.65 | -16.3% | Dec 9, 2025 |
| RBC Capital | Analyst unavailable | $302 | $249.02 | -17.6% | Nov 18, 2025 |
| KeyBanc | Analyst unavailable | $300 | $261.3 | -18.2% | Oct 31, 2025 |
| RBC Capital | Deane Dray | $262 | $260.04 | -28.6% | Oct 31, 2025 |
| Robert W. Baird | Analyst unavailable | $300 | $249.61 | -18.2% | Oct 31, 2025 |
| Barclays | Analyst unavailable | $258 | $213.98 | -29.6% | Oct 7, 2025 |
| Oppenheimer | Christopher Glynn | $255 | $219.18 | -30.5% | Sep 5, 2025 |
| KeyBanc | Ken Newman | $258 | $225.51 | -29.6% | Aug 29, 2025 |
| Loop Capital Markets | Chris Dankert | $235 | $206.74 | -35.9% | Aug 5, 2025 |
| KeyBanc | Ken Newman | $245 | $206.5 | -33.2% | Dec 9, 2024 |
| Loop Capital Markets | Chris Dankert | $250 | $209.16 | -31.8% | Nov 14, 2024 |
| Robert W. Baird | David Manthey | $550 | $172.45 | +50.0% | Oct 16, 2024 |
| Robert W. Baird | David Manthey | $215 | $172.45 | -41.4% | Oct 16, 2024 |
| Robert W. Baird | David Manthey | $172 | $167.34 | -53.1% | Sep 17, 2024 |
| Loop Capital Markets | Chris Dankert | $190 | $153.32 | -48.2% | Aug 6, 2024 |
| KeyBanc | Ken Newman | $195 | $158.75 | -46.8% | Aug 2, 2024 |
| Robert W. Baird | David Manthey | $195 | $185.52 | -46.8% | May 29, 2024 |
| Loop Capital Markets | Chris Dankert | $200 | $167.7 | -45.5% | May 6, 2024 |
| KeyBanc | Ken Newman | $205 | $165.08 | -44.1% | May 3, 2024 |
| RBC Capital | Deane Dray | $172 | $165.08 | -53.1% | May 3, 2024 |
| Wolfe Research | Nigel Coe | $215 | $171.79 | -41.4% | Apr 8, 2024 |
| Jefferies | Stephen Volkmann | $185 | $162.02 | -49.6% | Mar 12, 2024 |
| Raymond James | Analyst unavailable | $190 | $140.14 | -48.2% | May 6, 2022 |
| Loop Capital Markets | Chris Dankert | $170 | $129.12 | -53.6% | Feb 16, 2022 |
Track every rating change on WCC the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.